1 of 1
Story summary
- A new study suggests GLP-1 weight-loss drugs such as Ozempic and Wegovy may help prevent no-reflow after heart attacks.
- Researchers from the University of Bristol and University College London found these drugs could improve blood flow by activating potassium channels in heart cells.
- This repurposing could allow paramedics to administer these medications during emergencies.
- But findings remain based on animal models and require human trials to confirm benefits for recovery.
